Alpine Global Management’s G1 Therapeutics GTHX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2024
Q3
– Sell
-46,728
Closed -$107K – 512
2024
Q2
$107K Buy
+46,728
New +$178K 0.02% 403
2023
Q1
– Sell
-24,085
Closed -$131K – 462
2022
Q4
$131K Buy
+24,085
New +$202K 0.04% 121
2020
Q1
– Sell
-15,760
Closed -$417K – 467
2019
Q4
$417K Buy
+15,760
New +$369K 0.09% 188

Alpine Global Management's GTHX Position: Q3 2024 in Review

Alpine Global Management sold out of G1 Therapeutics (GTHX) in Q3 2024, closing a stake of 46,728 shares — an estimated $107K sold.

Alpine Global Management first reported a position in GTHX in Q4 2019 and held it in 3 quarters. The position peaked at $417K in Q4 2019. 0 funds tracked by Wall St. Rank hold GTHX as of Q3 2024.

  • Alpine Global Management reported no remaining G1 Therapeutics position as of Q3 2024 after selling out during the quarter.
  • Alpine Global Management sold 46,728 G1 Therapeutics shares in Q3 2024, an estimated $107K.
  • Alpine Global Management first reported a position in G1 Therapeutics in Q4 2019 and held it in 3 quarters.
  • Alpine Global Management's G1 Therapeutics position peaked at $417K in Q4 2019.
  • 0 funds tracked by Wall St. Rank held G1 Therapeutics as of Q3 2024.

Based on Alpine Global Management's 13F filing for Q3 2024, filed 14 Nov 2024.